Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 259131, 27 pages
http://dx.doi.org/10.1155/2014/259131
Review Article

Novel Insights into miRNA in Lung and Heart Inflammatory Diseases

1Laboratory of Immunogenomics and Immunoproteomics, Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 77515 Olomouc, Czech Republic
2Department of Internal Medicine I-Cardiology, Faculty of Medicine and Dentistry, Palacky University, 77520 Olomouc, Czech Republic

Received 15 November 2013; Revised 3 March 2014; Accepted 21 April 2014; Published 27 May 2014

Academic Editor: Giovanna Castoldi

Copyright © 2014 Amit Kishore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Buckingham, “The major world of microRNAs,” in Proceedings of the 2nd Horizon Symposium: Understanding the RNAissance, Nature Publishing Group, Scarborough, Me, USA, 2003.
  2. R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Pasquinelli, B. J. Reinhart, F. Slack et al., “Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA,” Nature, vol. 408, no. 6808, pp. 86–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Reinhart, F. J. Slack, M. Basson et al., “The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans,” Nature, vol. 403, no. 6772, pp. 901–906, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Blondal, S. J. Nielsen, A. Baker et al., “Assessing sample and miRNA profile quality in serum and plasma or other biofluids,” Methods, vol. 59, no. 1, pp. S1–S6, 2013. View at Publisher · View at Google Scholar
  6. E. P. Murchison and G. J. Hannon, “miRNAs on the move: miRNA biogenesis and the RNAi machinery,” Current Opinion in Cell Biology, vol. 16, no. 3, pp. 223–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Y. Lee, K. Zhou, A. M. Smith, C. L. Noland, and J. A. Doudna, “Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing,” Nucleic Acids Research, vol. 41, no. 13, pp. 6568–6576, 2013. View at Publisher · View at Google Scholar
  8. R. Sessa and A. Hata, “Role of microRNAs in lung development and pulmonary diseases,” Pulmonary Circulation, vol. 3, no. 2, pp. 315–328, 2013. View at Google Scholar
  9. R. M. O'Connell, D. S. Rao, A. A. Chaudhuri, and D. Baltimore, “Physiological and pathological roles for microRNAs in the immune system,” Nature Reviews Immunology, vol. 10, no. 2, pp. 111–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Yue, “miRNA and vascular cell movement,” Advanced Drug Delivery Reviews, vol. 63, no. 8, pp. 616–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Tan, G. Randall, J. Fan et al., “Allele-specific targeting of microRNAs to HLA-G and risk of asthma,” American Journal of Human Genetics, vol. 81, no. 4, pp. 829–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-W. Su, Y. Yang, M.-L. Lv et al., “Association between single-nucleotide polymorphisms in pre-miRNAs and the risk of asthma in a Chinese population,” DNA and Cell Biology, vol. 30, no. 11, pp. 919–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Jimenez-Morales, R. Gamboa-Becerra, V. Baca et al., “MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients,” Tissue Antigens, vol. 80, no. 4, pp. 317–321, 2012. View at Publisher · View at Google Scholar
  14. R. W. Lung, X. Wang, J. Hung-Man et al., “A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma,” Molecular Carcinogenesis, vol. 52, supplement 1, pp. 28–38, 2013. View at Publisher · View at Google Scholar
  15. J. Nicodemus-Johnson, B. Laxman, R. K. Stern et al., “Maternal asthma and microRNA regulation of soluble HLA-G in the airway,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1496–1503, 2013. View at Google Scholar
  16. Z. Hu, J. Chen, T. Tian et al., “Genetic variants of miRNA sequences and non-small cell lung cancer survival,” The Journal of Clinical Investigation, vol. 118, no. 7, pp. 2600–2608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Yoon, H. Yoon, S. Park et al., “The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 4, pp. 794–807, 2012. View at Publisher · View at Google Scholar
  18. T. Tian, Y. Shu, J. Chen et al., “A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese,” Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 4, pp. 1183–1187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Vinci, S. Gelmini, N. Pratesi et al., “Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 12, pp. 2073–2080, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wang, Q. Wang, H. Liu et al., “The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies,” Mutagenesis, vol. 27, no. 6, pp. 779–788, 2012. View at Publisher · View at Google Scholar
  21. Z. Yuan, X. Zeng, D. Yang, W. Wang, and Z. Liu, “Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk,” PLoS ONE, vol. 8, no. 4, article e61047, 2013. View at Publisher · View at Google Scholar
  22. L.-X. Qiu, Y. Wang, Z.-G. Xia et al., “miR-196a2 C allele is a low-penetrant risk factor for cancer development,” Cytokine, vol. 56, no. 3, pp. 589–592, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Wang, Y.-L. Ma, P. Zhang et al., “A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis,” Molecular Biology Reports, vol. 39, no. 1, pp. 269–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Xu, Z. Hu, Z. Xu et al., “Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population,” Human Mutation, vol. 30, no. 8, pp. 1231–1236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L.-J. Li, L.-B. Gao, M.-L. Lv et al., “Association between SNPs in pre-miRNA and risk of chronic obstructive pulmonary disease,” Clinical Biochemistry, vol. 44, no. 10-11, pp. 813–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Li, T. Wang, X. Song et al., “Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population,” Human Immunology, vol. 72, no. 7, pp. 598–602, 2011. View at Publisher · View at Google Scholar
  27. K. D. Taganov, M. P. Boldin, K.-J. Chang, and D. Baltimore, “NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12481–12486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Hikami, A. Kawasaki, I. Ito et al., “Association of a functional polymorphism in the 3′-untranslated region of SPI1 with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 63, no. 3, pp. 755–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Luo, W. Yang, D.-Q. Ye et al., “A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus,” PLoS Genetics, vol. 7, no. 6, article e1002128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. X. Leng, W. Wang, H. Cen et al., “Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus,” PLoS ONE, vol. 7, no. 12, article e51090, 2012. View at Publisher · View at Google Scholar
  31. S. E. Lofgren, J. Frostegård, L. Truedsson et al., “Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene,” Genes & Immunity, vol. 13, no. 3, pp. 268–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Deng, J. Zhao, D. Sakurai et al., “MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus,” PLoS Genetics, vol. 9, no. 2, article e1003336, 2013. View at Publisher · View at Google Scholar
  33. F. Amato, M. Seia, S. Giordano et al., “Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis?” PLoS ONE, vol. 8, no. 3, article e60448, 2013. View at Publisher · View at Google Scholar
  34. Y. Tang, X. Luo, H. Cui et al., “MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins,” Arthritis & Rheumatism, vol. 60, no. 4, pp. 1065–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. T. S. Elton, S. E. Sansom, and M. M. Martin, “Cardiovascular disease, single nucleotide polymorphisms, and the renin angiotensin system: is there a microRNA connection?” International Journal of Hypertension, vol. 2010, Article ID 281692, 13 pages, 2010. View at Publisher · View at Google Scholar
  36. P. Sethupathy, C. Borel, M. Gagnebin et al., “Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes,” American Journal of Human Genetics, vol. 81, no. 2, pp. 405–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Haas, G. Sczakiel, and S. D. Laufer, “MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3′-UTR via altered RNA structure,” RNA Biology, vol. 9, no. 6, pp. 924–937, 2012. View at Publisher · View at Google Scholar
  38. B. Mopidevi, M. Ponnala, and A. Kumar, “Human angiotensinogen +11525 C/A polymorphism modulates its gene expression through microRNA binding,” Physiological Genomics, vol. 45, no. 19, pp. 901–906, 2013. View at Publisher · View at Google Scholar
  39. C. Wu, Y. Gong, A. Sun et al., “The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 23, no. 7, pp. 693–698, 2013. View at Publisher · View at Google Scholar
  40. S.-L. Ding, J.-X. Wang, J.-Q. Jiao et al., “A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis,” The Journal of Biological Chemistry, vol. 288, no. 37, pp. 26865–26877, 2013. View at Publisher · View at Google Scholar
  41. B. Zhou, L. Rao, Y. Peng et al., “Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy,” Clinica Chimica Acta, vol. 411, no. 17-18, pp. 1287–1290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Sethupathy, “Illuminating microRNA transcription from the epigenome,” Current Genomics, vol. 14, no. 1, pp. 68–77, 2013. View at Publisher · View at Google Scholar
  43. T. A. Volpe, C. Kidner, I. M. Hall, G. Teng, S. I. S. Grewal, and R. A. Martienssen, “Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi,” Science, vol. 297, no. 5588, pp. 1833–1837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Baer, R. Claus, and C. Plass, “Genome-wide epigenetic regulation of miRNAs in cancer,” Cancer Research, vol. 73, no. 2, pp. 473–477, 2013. View at Publisher · View at Google Scholar
  45. C.-W. Lin, Y.-L. Chang, Y.-C. Chang et al., “MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1,” Nature Communications, vol. 4, Article ID 1877, 2013. View at Publisher · View at Google Scholar
  46. M. Fabbri, R. Garzon, A. Cimmino et al., “MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 40, pp. 15805–15810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Lujambio and S. W. Lowe, “The microcosmos of cancer,” Nature, vol. 482, no. 7385, pp. 347–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Brueckner, C. Stresemann, R. Kuner et al., “The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function,” Cancer Research, vol. 67, no. 4, pp. 1419–1423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Kunej, I. Godnic, J. Ferdin, S. Horvat, P. Dovc, and G. A. Calin, “Epigenetic regulation of microRNAs in cancer: an integrated review of literature,” Mutation Research, vol. 717, no. 1-2, pp. 77–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Tanaka, S. Toyooka, J. Soh et al., “Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer,” Lung Cancer, vol. 76, no. 1, pp. 32–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Lodygin, V. Tarasov, A. Epanchintsev et al., “Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer,” Cell Cycle, vol. 7, no. 16, pp. 2591–2600, 2008. View at Google Scholar · View at Scopus
  52. B. Richardson, “Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells,” Human Immunology, vol. 17, no. 4, pp. 456–470, 1986. View at Google Scholar · View at Scopus
  53. B. Richardson, L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson, “Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis,” Arthritis & Rheumatism, vol. 33, no. 11, pp. 1665–1673, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Deng, Q. Lu, Z. Zhang et al., “Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling,” Arthritis & Rheumatism, vol. 48, no. 3, pp. 746–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Hughes and A. H. Sawalha, “The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 13, no. 5, article 245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Pan, S. Zhu, M. Yuan et al., “MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1,” The Journal of Immunology, vol. 184, no. 12, pp. 6773–6781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Zhao, Y. Wang, Y. Liang et al., “MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1,” Arthritis & Rheumatism, vol. 63, no. 5, pp. 1376–1386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Qin, X. Zhu, J. Liang et al., “MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1,” Journal of Dermatological Science, vol. 69, no. 1, pp. 61–67, 2013. View at Publisher · View at Google Scholar
  59. M. Movassagh, M.-K. Choy, M. Goddard, M. R. Bennett, T. A. Down, and R. S.-Y. Foo, “Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure,” PLoS ONE, vol. 5, no. 1, article e8564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Udali, P. Guarini, S. Moruzzi, S.-W. Choi, and S. Friso, “Cardiovascular epigenetics: from DNA methylation to microRNAs,” Molecular Aspects of Medicine, vol. 34, no. 4, pp. 883–901, 2013. View at Publisher · View at Google Scholar
  61. S. Yang, S. Banerjee, A. de Freitas et al., “Participation of miR-200 in pulmonary fibrosis,” The American Journal of Pathology, vol. 180, no. 2, pp. 484–493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Liu, A. Friggeri, Y. Yang et al., “miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis,” The Journal of Experimental Medicine, vol. 207, no. 8, pp. 1589–1597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Honeyman, M. Bazett, T. G. Tomko, and C. K. Haston, “MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice,” Fibrogenesis & Tissue Repair, vol. 6, no. 1, article 16, 2013. View at Publisher · View at Google Scholar
  64. P. Li, G.-Q. Zhao, T.-F. Chen et al., “Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis,” The Journal of Asthma, vol. 50, no. 9, pp. 960–964, 2013. View at Google Scholar
  65. S. Vettori, S. Gay, and O. Distler, “Role of microRNAs in fibrosis,” The Open Rheumatology Journal, vol. 6, pp. 130–139, 2012. View at Publisher · View at Google Scholar
  66. T. Sato, X. Liu, A. Nelson et al., “Reduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblasts,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 8, pp. 1020–1029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Tsitsiou, A. E. Williams, S. A. Moschos et al., “Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma,” The Journal of Allergy and Clinical Immunology, vol. 129, no. 1, pp. 95–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Pinkerton, V. Chinchilli, E. Banta et al., “Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults,” The Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 217–219, 2013. View at Google Scholar
  69. Y. Fujita, F. Takeshita, K. Kuwano, and T. Ochiya, “RNAi therapeutic platforms for lung diseases,” Pharmaceuticals, vol. 6, no. 2, pp. 223–250, 2013. View at Publisher · View at Google Scholar
  70. T. Tomankova, M. Petrek, and E. Kriegova, “Involvement of microRNAs in physiological and pathological processes in the lung,” Respiratory Research, vol. 11, article 159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Dakhlallah, K. Batte, Y. Wang et al., “Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 397–405, 2013. View at Publisher · View at Google Scholar
  72. L. Renaud, H. Kasiganesan, E. Gao et al., “Regulation of miR-21 expression by acetylation in myocardial infarction,” Circulation Research, vol. 111, no. 4, 2012. View at Google Scholar
  73. M. Wills-Karp, J. Luyimbazi, X. Xu et al., “Interleukin-13: central mediator of allergic asthma,” Science, vol. 282, no. 5397, pp. 2258–2261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. T. X. Lu and M. E. Rothenberg, “Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases,” The Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 3–14, 2013. View at Google Scholar
  75. J. Mattes, A. Collison, M. Plank, S. Phipps, and P. S. Foster, “Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 44, pp. 18704–18709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Chiba, M. Tanabe, K. Goto, H. Sakai, and M. Misawa, “Down-regulation of miR-133a contributes to up-regulation of RhoA in bronchial smooth muscle cells,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 8, pp. 713–719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Levanen, N. R. Bhakta, P. T. Paredes et al., “Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 894–903, 2013. View at Publisher · View at Google Scholar
  78. S. Soeda, J. H. Ohyashiki, K. Ohtsuki, T. Umezu, Y. Setoguchi, and K. Ohyashiki, “Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease,” International Journal of Molecular Medicine, vol. 31, no. 3, pp. 533–539, 2013. View at Publisher · View at Google Scholar
  79. P. Leidinger, A. Keller, A. Borries et al., “Specific peripheral miRNA profiles for distinguishing lung cancer from COPD,” Lung Cancer, vol. 74, no. 1, pp. 41–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Sanfiorenzo, M. I. Ilie, A. Belaid et al., “Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC,” PLoS ONE, vol. 8, no. 1, article e54596, 2013. View at Publisher · View at Google Scholar
  81. M. Kumar, T. Ahmad, A. Sharma et al., “Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation,” The Journal of Allergy and Clinical Immunology, vol. 128, no. 5, pp. 1077.e10–1085.e10, 2011. View at Google Scholar
  82. C. Song, H. Ma, C. Yao, X. Tao, and H. Gan, “Alveolar macrophage-derived vascular endothelial growth factor contributes to allergic airway inflammation in a mouse asthma model,” Scandinavian Journal of Immunology, vol. 75, no. 6, pp. 599–605, 2012. View at Publisher · View at Google Scholar
  83. T. X. Lu, A. Munitz, and M. E. Rothenberg, “MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression,” The Journal of Immunology, vol. 182, no. 8, pp. 4994–5002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Sharma, M. Kumar, T. Ahmad et al., “Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model,” Journal of Applied Physiology, vol. 113, no. 3, pp. 459–464, 2012. View at Publisher · View at Google Scholar
  85. A. Sharma, M. Kumar, J. Aich et al., “Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5761–5766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Collison, C. Herbert, J. S. Siegle, J. Mattes, P. S. Foster, and R. K. Kumar, “Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target,” BMC Pulmonary Medicine, vol. 11, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Collison, J. Mattes, M. Plank, and P. S. Foster, “Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment,” The Journal of Allergy and Clinical Immunology, vol. 128, no. 1, pp. 160.e4–167.e4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. M. J. Feng, F. Shi, C. qiu, and W.-K. Peng, “MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma,” International Immunopharmacology, vol. 13, no. 3, pp. 347–353, 2012. View at Publisher · View at Google Scholar
  89. Y. Zheng, S. Xiong, P. Jiang et al., “Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism,” Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1307–1317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. R. J. Mayoral, L. Deho, N. Rusca et al., “MiR-221 influences effector functions and actin cytoskeleton in mast cells,” PLoS ONE, vol. 6, no. 10, article e26133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. M. M. Perry, J. E. Baker, D. S. Gibeon, I. M. Adcock, and K. E. Chung, “Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 1, pp. 7–17, 2014. View at Publisher · View at Google Scholar
  92. G. R. Pottelberge, P. Mestdagh, K. R. Bracke et al., “MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 7, pp. 898–906, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Lewis, J. Riddoch-Contreras, S. A. Natanek et al., “Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD,” Thorax, vol. 67, no. 1, pp. 26–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Donaldson, S. A. Natanek, A. Lewis et al., “Increased skeletal muscle-specific microRNA in the blood of patients with COPD,” Thorax, vol. 68, no. 12, pp. 1140–1149, 2013. View at Publisher · View at Google Scholar
  95. F. Akbas, E. Coskunpinar, E. Aynacı, Y. M. Oltulu, and P. Yildiz, “Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease,” Experimental Lung Research, vol. 38, no. 6, pp. 286–294, 2012. View at Publisher · View at Google Scholar
  96. M. E. Ezzie, M. Crawford, J.-H. Cho et al., “Gene expression networks in COPD: microRNA and mRNA regulation,” Thorax, vol. 67, no. 2, pp. 122–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. F. Schembri, S. Sridhar, C. Perdomo et al., “MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2319–2324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. F. Hassan, G. J. Nuovo, M. Crawford et al., “MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung,” PLoS ONE, vol. 7, no. 11, article e50837, 2012. View at Publisher · View at Google Scholar
  99. J. W. Graff, L. S. Powers, A. M. Dickson et al., “Cigarette smoking decreases global microRNA expression in human alveolar macrophages,” PLoS ONE, vol. 7, no. 8, article e44066, 2012. View at Publisher · View at Google Scholar
  100. A. E. Gillen, N. Gosalia, S.-H. Leir, and A. Harris, “microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene,” The Biochemical Journal, vol. 438, no. 1, pp. 25–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. F. Megiorni, S. Cialfi, C. Dominici, S. Quattrucci, and A. Pizzuti, “Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by miR-101 and miR-494 specific binding,” PLoS ONE, vol. 6, no. 10, article e26601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. I. K. Oglesby, I. M. Bray, S. H. Chotirmall et al., “miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression,” The Journal of Immunology, vol. 184, no. 4, pp. 1702–1709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Ramachandran, P. H. Karp, P. Jiang et al., “A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 33, pp. 13362–13367, 2012. View at Publisher · View at Google Scholar
  104. I. K. Oglesby, S. H. Chotirmall, N. G. McElvaney, and C. M. Greene, “Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium,” The Journal of Immunology, vol. 190, no. 7, pp. 3354–3362, 2013. View at Publisher · View at Google Scholar
  105. F. Megiorni, S. Cialfi, G. Cimino et al., “Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients,” Journal of Cystic Fibrosis, vol. 12, no. 6, pp. 797–802, 2013. View at Publisher · View at Google Scholar
  106. N. Pottier, T. Maurin, B. Chevalier et al., “Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions,” PLoS ONE, vol. 4, no. 8, article e6718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Bhattacharyya, N. S. Balakathiresan, C. Dalgard et al., “Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8,” The Journal of Biological Chemistry, vol. 286, no. 13, pp. 11604–11615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Tsuchiya, P. Kumar, S. Bhattacharyya et al., “Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells,” Journal of Interferon & Cytokine Research, vol. 33, no. 3, pp. 121–129, 2013. View at Publisher · View at Google Scholar
  109. S. Bhattacharyya, P. Kumar, M. Tsuchiya, A. Bhattacharyya, and R. Biswas, “Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP,” Biochemical and Biophysical Research Communications, vol. 433, no. 4, pp. 484–488, 2013. View at Publisher · View at Google Scholar
  110. S. Ramachandran, P. H. Karp, S. R. Osterhaus et al., “Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 4, pp. 544–551, 2013. View at Publisher · View at Google Scholar
  111. K. V. Pandit, D. Corcoran, H. Yousef et al., “Inhibition and role of let-7d in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 2, pp. 220–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. S. R. Oak, L. Murray, A. Herath et al., “A microRNA processing defect in rapidly progressing idiopathic pulmonary fibrosis,” PLoS ONE, vol. 6, no. 6, article e21253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. D. Dakhlallah, Cross-talk between epigenetic regulation and Mir-17~92 cluster expression in idiopathic pulmonary fibrosis (IPF) [Ph.D. dissertation], The Ohio State University, Columbus, Ohio, USA, 2011.
  114. M. Yamada, H. Kubo, C. Ota et al., “The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells,” Respiratory Research, vol. 14, no. 1, article 95, 2013. View at Publisher · View at Google Scholar
  115. L. Cushing, P. P. Kuang, J. Qian et al., “miR-29 is a major regulator of genes associated with pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 2, pp. 287–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. K. V. Pandit, J. Milosevic, and N. Kaminski, “MicroRNAs in idiopathic pulmonary fibrosis,” Translational Research, vol. 157, no. 4, pp. 191–199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Xiao, X.-M. Meng, X. R. Huang et al., “miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice,” Molecular Therapy, vol. 20, no. 6, pp. 1251–1260, 2012. View at Publisher · View at Google Scholar
  118. J. Milosevic, K. Pandit, M. Magister et al., “Profibrotic role of miR-154 in pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 6, pp. 879–887, 2012. View at Publisher · View at Google Scholar
  119. T. Xie, J. Liang, N. Liu et al., “MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I,” The Journal of Immunology, vol. 188, no. 5, pp. 2437–2444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Vaporidi, E. Vergadi, E. Kaniaris et al., “Pulmonary microRNA profiling in a mouse model of ventilator-induced lung injury,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 303, no. 3, pp. L199–L207, 2012. View at Publisher · View at Google Scholar
  121. N. Yehya, A. Yerrapureddy, J. Tobias, and S. S. Margulies, “MicroRNA modulate alveolar epithelial response to cyclic stretch,” BMC Genomics, vol. 13, article 154, 2012. View at Publisher · View at Google Scholar
  122. Z. Zeng, H. Gong, Y. Li et al., “Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury,” Experimental Lung Research, vol. 39, no. 7, pp. 275–282, 2013. View at Publisher · View at Google Scholar
  123. M. M. Perry, S. A. Moschos, A. E. Williams, N. J. Shepherd, H. M. Larner-Svensson, and M. A. Lindsay, “Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells1,” The Journal of Immunology, vol. 180, no. 8, pp. 5689–5698, 2008. View at Google Scholar · View at Scopus
  124. X. Sun, B. Icli, A. K. Wara et al., “MicroRNA-181b regulates NF-κB-mediated vascular inflammation,” The Journal of Clinical Investigation, vol. 122, no. 6, pp. 1973–1990, 2012. View at Publisher · View at Google Scholar
  125. M. Brock, M. Trenkmann, R. E. Gay et al., “Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway,” Circulation Research, vol. 104, no. 10, pp. 1184–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. J. Sarkar, D. Gou, P. Turaka, E. Viktorova, R. Ramchandran, and J. U. Raj, “MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 299, no. 6, pp. L861–L871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Yang, S. Banerjee, A. de Freitas et al., “miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 302, no. 6, pp. L521–L529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. C. Y. Wei, H. Henderson, C. Spradley et al., “Circulating miRNAs as potential marker for pulmonary hypertension,” PLoS ONE, vol. 8, no. 5, article e64396, 2013. View at Publisher · View at Google Scholar
  129. K. Kang, X. Peng, X. Zhang et al., “MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells,” The Journal of Biological Chemistry, vol. 288, no. 35, pp. 25414–25427, 2013. View at Publisher · View at Google Scholar
  130. P. Caruso, Y. Dempsie, H. C. Stevens et al., “A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples,” Circulation Research, vol. 111, no. 3, pp. 290–300, 2012. View at Publisher · View at Google Scholar
  131. A. Courboulin, R. Paulin, N. J. Giguère et al., “Role for miR-204 in human pulmonary arterial hypertension,” Journal of Experimental Medicine, vol. 208, no. 3, pp. 535–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. S. Jalali, G. K. Ramanathan, P. T. Parthasarathy et al., “Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation,” PLoS ONE, vol. 7, no. 10, article e46808, 2012. View at Publisher · View at Google Scholar
  133. J. Yue, J. Guan, X. Wang et al., “MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1α/Fhl-1 pathway,” Laboratory Investigation, vol. 93, no. 7, pp. 748–759, 2013. View at Publisher · View at Google Scholar
  134. J. Kim, Y. Kang, Y. Kojima et al., “An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension,” Nature Medicine, vol. 19, no. 1, pp. 74–82, 2013. View at Publisher · View at Google Scholar
  135. G. Raghu, H. R. Collard, J. J. Egan et al., “An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 6, pp. 788–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Yang, G.-F. Zhang, X.-F. Chen et al., “MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2,” Biochemical and Biophysical Research Communications, vol. 436, no. 4, pp. 578–584, 2013. View at Publisher · View at Google Scholar
  137. E. Orenes-Pinero, S. Montoro-García, J. V. Patel, M. Valdés, F. Marín, and G. Y. Lip, “Role of microRNAs in cardiac remodelling: new insights and future perspectives,” International Journal of Cardiology, vol. 167, no. 5, pp. 1651–1659, 2013. View at Publisher · View at Google Scholar
  138. G. Condorelli, M. V. Latronico, and E. Cavarretta, “microRNAs in cardiovascular diseases: current knowledge and the road ahead,” Journal of the American College of Cardiology, 2014. View at Publisher · View at Google Scholar
  139. P. Libby, “Inflammation and cardiovascular disease mechanisms,” The American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 456S–460S, 2006. View at Google Scholar
  140. L. Xiao, Y. Liu, and N. Wang, “New paradigms in inflammatory signaling in vascular endothelial cells,” American Journal of Physiology: Heart and Circulatory Physiology, 2013. View at Publisher · View at Google Scholar
  141. J. Bauersachs and T. Thum, “Biogenesis and regulation of cardiovascular microRNAs,” Circulation Research, vol. 109, no. 3, pp. 334–347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  142. R. Ranjha and J. Paul, “Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer,” Inflammation Research, vol. 62, no. 4, pp. 343–355, 2013. View at Google Scholar
  143. E. Raitoharju, L.-P. Lyytikäinen, M. Levula et al., “miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study,” Atherosclerosis, vol. 219, no. 1, pp. 211–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. K. Bidzhekov, L. Gan, B. Denecke et al., “microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans,” Thrombosis and Haemostasis, vol. 107, no. 4, pp. 619–625, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. K.-C. Chen, Y.-C. Liao, I.-C. Hsieh, Y.-S. Wang, C.-Y. Hu, and S.-H. H. Juo, “OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: novel mechanisms for cardiovascular diseases,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 3, pp. 587–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. X. Sun, S. He, A. K. Wara et al., “Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice,” Circulation Research, vol. 114, no. 1, pp. 32–40, 2014. View at Publisher · View at Google Scholar
  147. D. J. Son, S. Kumar, W. Takabe et al., “The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis,” Nature Communications, vol. 4, Article ID 3000, 2013. View at Publisher · View at Google Scholar
  148. G. Long, F. Wang, Q. Duan et al., “Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction,” PLoS ONE, vol. 7, no. 12, article e50926, 2012. View at Publisher · View at Google Scholar
  149. J. Ai, R. Zhang, Y. Li et al., “Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 73–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. S. Dimmeler and A. M. Zeiher, “Circulating microRNAs: novel biomarkers for cardiovascular diseases?” European Heart Journal, vol. 31, no. 22, pp. 2705–2707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. S. K. Gupta, C. Bang, and T. Thum, “Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease,” Circulation: Cardiovascular Genetics, vol. 3, no. 5, pp. 484–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. Y. Cheng, N. Tan, J. Yang et al., “A translational study of circulating cell-free microRNA-1 in acute myocardial infarction,” Clinical Science, vol. 119, no. 2, pp. 87–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. G. Long, F. Wang, Q. Duan et al., “Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction,” International Journal of Biological Sciences, vol. 8, no. 6, pp. 811–818, 2012. View at Publisher · View at Google Scholar
  154. G.-K. Wang, J.-Q. Zhu, J.-T. Zhang et al., “Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans,” European Heart Journal, vol. 31, no. 6, pp. 659–666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Dong, Y. Cheng, J. Yang et al., “MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction,” The Journal of Biological Chemistry, vol. 284, no. 43, pp. 29514–29525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. Y. D'Alessandra, P. Devanna, F. Limana et al., “Circulating microRNAs are new and sensitive biomarkers of myocardial infarction,” European Heart Journal, vol. 31, no. 22, pp. 2765–2773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. R. Wang, N. Li, Y. Zhang, Y. Ran, and J. Pu, “Circulating microRNAs are promising novel biomarkers of acute myocardial infarction,” Internal Medicine, vol. 50, no. 17, pp. 1789–1795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. A. J. Tijsen, Y. M. Pinto, and E. E. Creemers, “Non-cardiomyocyte microRNAs in heart failure,” Cardiovascular Research, vol. 93, no. 4, pp. 573–582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. M. F. Corsten, R. Dennert, S. Jochems et al., “Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease,” Circulation: Cardiovascular Genetics, vol. 3, no. 6, pp. 499–506, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. T. Adachi, M. Nakanishi, Y. Otsuka et al., “Plasma microRNA 499 as a biomarker of acute myocardial infarction,” Clinical Chemistry, vol. 56, no. 7, pp. 1183–1185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  161. Q. Li, X.-W. Song, J. Zou et al., “Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy,” Journal of Cell Science, vol. 123, part 14, pp. 2444–2452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  162. Y. Cheng, R. Ji, J. Yue et al., “MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a pole in cardiac hypertrophy?” The American Journal of Pathology, vol. 170, no. 6, pp. 1831–1840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. Z. P. Huang, J. Chen, H. Y. Seok et al., “MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress,” Circulation Research, vol. 112, no. 9, pp. 1234–1243, 2013. View at Google Scholar
  164. J. Wang, Y. Song, Y. Zhang et al., “Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice,” Cell Research, vol. 22, no. 3, pp. 516–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  165. R. Roncarati, C. V. Anselmi, M. A. Losi et al., “Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 63, no. 9, pp. 920–927, 2014. View at Publisher · View at Google Scholar
  166. W. Pan, Y. Zhong, C. Cheng et al., “MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy,” PLoS ONE, vol. 8, no. 1, article e53950, 2013. View at Publisher · View at Google Scholar
  167. A. Care, D. Catalucci, F. Felicetti et al., “MicroRNA-133 controls cardiac hypertrophy,” Nature Medicine, vol. 13, no. 5, pp. 613–618, 2007. View at Google Scholar
  168. D.-L. Dong, C. Chen, R. Huo et al., “Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy,” Hypertension, vol. 55, no. 4, pp. 946–952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. S. Heymans, M. E. Corsten, W. Verhesen et al., “Macrophage microRNA-155 promotes cardiac hypertrophy and failure,” Circulation, vol. 128, no. 13, pp. 1420–1432, 2013. View at Google Scholar
  170. E. M. Small, R. J. A. Frost, and E. N. Olson, “MicroRNAs add a new dimension to cardiovascular disease,” Circulation, vol. 121, no. 8, pp. 1022–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  171. D. Sayed, M. He, Z. Yang, and M. Abdellatif, “MicroRNA-21 enhances AKT activity and reduces myocyte apoptosis and ischemic heart failure through suppression of PTEN,” Circulation, vol. 120, no. 18, article S838, 2009. View at Google Scholar
  172. Y. Tu, L. Wan, Y. Fan et al., “Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway,” PLoS ONE, vol. 8, no. 10, article e75872, 2013. View at Publisher · View at Google Scholar
  173. K. Kin, S. Miyagawa, S. Fukushima et al., “Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm,” Journal of the American Heart Association, vol. 1, no. 5, Article ID e000745, 2012. View at Publisher · View at Google Scholar
  174. G. Castoldi, C. R. T. di Gioia, C. Bombardi et al., “MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 850–856, 2012. View at Publisher · View at Google Scholar · View at Scopus
  175. C. Wei, I. K. Kim, S. Kumar et al., “NF-κB mediated miR-26a regulation in cardiac fibrosis,” Journal of Cellular Physiology, vol. 228, no. 7, pp. 1433–1442, 2013. View at Google Scholar
  176. R. F. Duisters, A. J. Tijsen, B. Schroen et al., “miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of micrornas in myocardial matrix remodeling,” Circulation Research, vol. 104, no. 2, pp. 170–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Beaumont, B. López, N. Hermida et al., “microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation,” Clinical Science, vol. 126, no. 7, pp. 497–506, 2014. View at Google Scholar
  178. S. Fichtlscherer, S. de Rosa, H. Fox et al., “Circulating microRNAs in patients with coronary artery disease,” Circulation Research, vol. 107, no. 5, pp. 677–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. V. P. van Empel, L. J. de Windt, and P. A. da Costa Martins, “Circulating miRNAs: reflecting or affecting cardiovascular disease?” Current Hypertension Reports, vol. 14, no. 6, pp. 498–509, 2012. View at Google Scholar
  180. J. Ren, J. Zhang, N. Xu et al., “Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease,” PLoS ONE, vol. 8, no. 12, article e80738, 2013. View at Publisher · View at Google Scholar
  181. M. Hoekstra, C. A. C. van der Lans, B. Halvorsen et al., “The peripheral blood mononuclear cell microRNA signature of coronary artery disease,” Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 792–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  182. S. Ikeda and W. T. Pu, “Expression and function of microRNAs in heart disease,” Current Drug Targets, vol. 11, no. 8, pp. 913–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. S. Roy, S. Khanna, S.-R. A. Hussain et al., “MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue,” Cardiovascular Research, vol. 82, no. 1, pp. 21–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. T. Thum, C. Gross, J. Fiedler et al., “MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts,” Nature, vol. 456, no. 7224, pp. 980–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. B. A. Dickinson, H. M. Semus, R. L. Montgomery et al., “Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure,” European Journal of Heart Failure, vol. 15, no. 6, pp. 650–659, 2013. View at Google Scholar
  186. Y. Fukushima, M. Nakanishi, H. Nonogi, Y. Goto, and N. Iwai, “Assessment of plasma miRNAs in congestive heart failure,” Circulation Journal, vol. 75, no. 2, pp. 336–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  187. N. Danowski, I. Manthey, H. G. Jakob, W. Siffert, J. Peters, and U. H. Frey, “Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery,” Cardiology, vol. 125, no. 2, pp. 125–130, 2013. View at Google Scholar
  188. R. L. Montgomery, T. G. Hullinger, H. M. Semus et al., “Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure,” Circulation, vol. 124, no. 14, pp. 1537–1547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  189. K. Endo, Y. Naito, X. Ji et al., “MicroRNA 210 as a biomarker for congestive heart failure,” Biological & Pharmaceutical Bulletin, vol. 36, no. 1, pp. 48–54, 2013. View at Google Scholar
  190. K. L. Fan, H. F. Zhang, J. Shen, Q. Zhang, and X. L. Li, “Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy,” Indian Heart Journal, vol. 65, no. 1, pp. 12–16, 2013. View at Google Scholar
  191. A. J. Tijsen, E. E. Creemers, P. D. Moerland et al., “MiR423-5p as a circulating biomarker for heart failure,” Circulation Research, vol. 106, no. 6, pp. 1035–1039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  192. Y. Goren, M. Kushnir, B. Zafrir, S. Tabak, B. S. Lewis, and O. Amir, “Serum levels of microRNAs in patients with heart failure,” European Journal of Heart Failure, vol. 14, no. 2, pp. 147–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  193. E. E. Creemers, A. J. Tijsen, and Y. M. Pinto, “Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?” Circulation Research, vol. 110, no. 3, pp. 483–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  194. V. Kinet, J. Halkein, E. Dirkx, and L. J. de Windt, “Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication,” Frontiers in Genetics, vol. 4, article 214, 2013. View at Publisher · View at Google Scholar
  195. A. J. Tijsen, Y. M. Pinto, and E. E. Creemers, “Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 303, no. 9, pp. H1085–H1095, 2012. View at Google Scholar
  196. E. M. Small and E. N. Olson, “Pervasive roles of microRNAs in cardiovascular biology,” Nature, vol. 469, no. 7330, pp. 336–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  197. E. van Rooij and E. N. Olson, “MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles,” Nature Reviews: Drug Discovery, vol. 11, no. 11, pp. 860–872, 2012. View at Google Scholar
  198. Y. Kuwabara, K. Ono, T. Horie et al., “Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage,” Circulation: Cardiovascular Genetics, vol. 4, no. 4, pp. 446–454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. I. P. Tereshchenko, J. Petrkova, M. I. Voevoda et al., “CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction,” Mediators of Inflammation, vol. 2011, Article ID 525691, 6 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  200. M. Nazari-Jahantigh, Y. Wei, H. Noels et al., “MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages,” The Journal of Clinical Investigation, vol. 122, no. 11, pp. 4190–4202, 2012. View at Google Scholar
  201. W.-J. Chen, K. Yin, G.-J. Zhao, Y.-C. Fu, and C.-K. Tang, “The magic and mystery of MicroRNA-27 in atherosclerosis,” Atherosclerosis, vol. 222, no. 2, pp. 314–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  202. Y. Wei, M. Nazari-Jahantigh, L. Chan et al., “The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis,” Circulation, vol. 127, no. 15, pp. 1609–1619, 2013. View at Google Scholar
  203. J. Zhu, T. Chen, Z. Li et al., “Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10,” PLoS ONE, vol. 7, no. 11, article e46551, 2012. View at Publisher · View at Google Scholar
  204. Y. Wei, M. Nazari-Jahantigh, P. Neth, C. Weber, and A. Schober, “MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 3, pp. 449–454, 2013. View at Google Scholar
  205. A. B. Aurora, A. I. Mahmoud, X. Luo et al., “MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1222–1232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  206. G. Vassalli and B. R. Winkelmann, “Molecular genetics of myocardial infarction: many genes, more questions than answers,” European Heart Journal, vol. 25, no. 6, pp. 451–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  207. C. Li, F. Pei, X. Zhu, D. D. Duan, and C. Zeng, “Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction,” Clinical Biochemistry, vol. 45, no. 10-11, pp. 727–732, 2012. View at Publisher · View at Google Scholar
  208. M. V. Latronico and G. Condorelli, “microRNAs in hypertrophy and heart failure,” Experimental Biology and Medicine, vol. 236, no. 2, pp. 125–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  209. M. Abdellatif, “The role of microRNA-133 in cardiac hypertrophy uncovered,” Circulation Research, vol. 106, no. 1, pp. 16–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. E. van Rooij, L. B. Sutherland, J. E. Thatcher et al., “Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13027–13032, 2008. View at Publisher · View at Google Scholar · View at Scopus
  211. Y. Cheng and C. Zhang, “MicroRNA-21 in cardiovascular disease,” Journal of Cardiovascular Translational Research, vol. 3, no. 3, pp. 251–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  212. H. Zhu and G.-C. Fan, “Role of microRNAs in the reperfused myocardium towards post-infarct remodelling,” Cardiovascular Research, vol. 94, no. 2, pp. 284–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  213. A. Banerjee and K. Luettich, “MicroRNAs as potential biomarkers of smoking-related diseases,” Biomarkers in Medicine, vol. 6, no. 5, pp. 671–684, 2012. View at Google Scholar
  214. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  215. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  216. A. Etheridge, I. Lee, L. Hood, D. Galas, and K. Wang, “Extracellular microRNA: a new source of biomarkers,” Mutation Research, vol. 717, no. 1-2, pp. 85–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  217. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al., “Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003–5008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  218. P. Diehl, A. Fricke, L. Sander et al., “Microparticles: major transport vehicles for distinct microRNAs in circulation,” Cardiovascular Research, vol. 93, no. 4, pp. 633–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  219. R. A. Boon and K. C. Vickers, “Intercellular transport of microRNAs,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 186–192, 2013. View at Google Scholar
  220. H. H. Cheng, H. S. Yi, Y. Kim et al., “Plasma processing conditions substantially influence circulating microRNA biomarker levels,” PLoS ONE, vol. 8, no. 6, article e64795, 2013. View at Publisher · View at Google Scholar
  221. K. Wang, Y. Yuan, J.-H. Cho, S. McClarty, D. Baxter, and D. J. Galas, “Comparing the MicroRNA spectrum between serum and plasma,” PLoS ONE, vol. 7, no. 7, article e41561, 2012. View at Publisher · View at Google Scholar
  222. J. A. Weber, D. H. Baxter, S. Zhang et al., “The microRNA spectrum in 12 body fluids,” Clinical Chemistry, vol. 56, no. 11, pp. 1733–1741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  223. S. de Rosa, S. Fichtlscherer, R. Lehmann, B. Assmus, S. Dimmeler, and A. M. Zeiher, “Transcoronary concentration gradients of circulating MicroRNAs,” Circulation, vol. 124, no. 18, pp. 1936–1944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  224. P. Willeit, A. Zampetaki, K. Dudek et al., “Circulating microRNAs as novel biomarkers for platelet activation,” Circulation Research, vol. 112, no. 4, pp. 595–600, 2013. View at Google Scholar
  225. C. C. Pritchard, H. H. Cheng, and M. Tewari, “MicroRNA profiling: approaches and considerations,” Nature Reviews Genetics, vol. 13, no. 5, pp. 358–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  226. Y. Huang, Q. Zou, S. P. Wang, S. M. Tang, G. Z. Zhang, and X. J. Shen, “The discovery approaches and detection methods of microRNAs,” Molecular Biology Reports, vol. 38, no. 6, pp. 4125–4135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  227. F. Russo, S. di Bella, G. Nigita et al., “miRandola: extracellular circulating microRNAs database,” PLoS ONE, vol. 7, no. 10, article e47786, 2012. View at Publisher · View at Google Scholar
  228. M. J. Lodes, M. Caraballo, D. Suciu, S. Munro, A. Kumar, and B. Anderson, “Detection of cancer with serum miRNAs on an oligonucleotide microarray,” PLoS ONE, vol. 4, no. 7, article e6229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  229. C. Chen, D. A. Ridzon, A. J. Broomer et al., “Real-time quantification of microRNAs by stem-loop RT-PCR,” Nucleic Acids Research, vol. 33, no. 20, article e179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  230. H.-J. Fu, J. Zhu, M. Yang et al., “A novel method to monitor the expression of microRNAs,” Molecular Biotechnology, vol. 32, no. 3, pp. 197–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  231. H. J. Peltier and G. J. Latham, “Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues,” RNA, vol. 14, no. 5, pp. 844–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  232. P. Mestdagh, P. van Vlierberghe, A. de Weer et al., “A novel and universal method for microRNA RT-qPCR data normalization,” Genome Biology, vol. 10, no. 6, article R64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  233. R. Garzon, G. Marcucci, and C. M. Croce, “Targeting microRNAs in cancer: rationale, strategies and challenges,” Nature Reviews: Drug Discovery, vol. 9, no. 10, pp. 775–789, 2010. View at Publisher · View at Google Scholar · View at Scopus